UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

First-line atezolizumab plus chemotherapy in treatment of extensive small cell lung cancer: a cost-effectiveness analysis from China

Chinese medical journal, 2019-12, Vol.132 (23), p.2790-2794

2019

Volltextzugriff (PDF)

A brand new era of cancer immunotherapy: breakthroughs and challenges

Chinese medical journal, 2021-06, Vol.134 (11), p.1267-1275

2021

Volltextzugriff (PDF)

The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively

Cancer medicine (Malden, MA), 2021-07, Vol.10 (14), p.4677-4696

2021

Volltextzugriff (PDF)

Cost‐effectiveness analysis of first‐line treatments for advanced epidermal growth factor receptor‐mutant non‐small cell lung cancer patients

Cancer medicine (Malden, MA), 2021-03, Vol.10 (6), p.1964-1974

2021

Volltextzugriff (PDF)

Sarcopenia prevalence in patients with cancer and association with adverse prognosis: A nationwide survey on common cancers

Nutrition (Burbank, Los Angeles County, Calif.), 2023-10, Vol.114, p.112107, Article 112107

2023

Volltextzugriff (PDF)

Chromosome structural variation in tumorigenesis: mechanisms of formation and carcinogenesis

Epigenetics & chromatin, 2020-11, Vol.13 (1), p.49-17, Article 49

2020

Volltextzugriff (PDF)

Association between GLIM-diagnosed malnutrition and quality of life in older patients with cancer

The Journal of nutrition, health & aging, 2024-06, Vol.28 (6), p.100274

2024

Volltextzugriff (PDF)

Integrated neutrophil-to-lymphocyte ratio and handgrip strength better predict survival in patients with cancer cachexia

Nutrition (Burbank, Los Angeles County, Calif.), 2024-06, Vol.122, p.112399-112399, Article 112399

2024

Volltextzugriff (PDF)

Cost-effectiveness of programmed cell death ligand 1 testing and tumor mutational burden testing of immune checkpoint inhibitors for advanced non-small cell lung cancer

Chinese medical journal, 2020-11, Vol.133 (21), p.2630-2632

2020

Volltextzugriff (PDF)

Association of Base Excision Repair Gene Polymorphisms with the Response to Chemotherapy in Advanced Non-Small Cell Lung Cancer

Chinese medical journal, 2018-08, Vol.131 (16), p.1904-1908

2018

Volltextzugriff (PDF)

Correlation of circulating tumor DNA EGFR mutation levels with clinical outcomes in patients with advanced lung adenocarcinoma

Chinese medical journal, 2021-10, Vol.134 (20), p.2430-2437

2021

Volltextzugriff (PDF)

Diverse and precision therapies open new horizons for patients with advanced pancreatic ductal adenocarcinoma

Hepatobiliary & pancreatic diseases international, 2022-02, Vol.21 (1), p.10-24

2022

Volltextzugriff (PDF)

The Role of Tumor-Infiltrating B Cells in Tumor Immunity

Journal of oncology, 2019, Vol.2019 (2019), p.1-9

2019

Volltextzugriff (PDF)

The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis

Blood, 2010-07, Vol.116 (3), p.428-436

2010

Volltextzugriff (PDF)

Lentivirus‑mediated MDA7/IL24 expression inhibits the proliferation of hepatocellular carcinoma cells

Molecular medicine reports, 2018-04, Vol.17 (4), p.5764-5773

2018

Volltextzugriff (PDF)

Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial

Cell research, 2023-05, Vol.33 (5), p.389-402

2023

Volltextzugriff (PDF)

First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial

Nature medicine, 2023-08, Vol.29 (8), p.2079-2086

2023

Volltextzugriff (PDF)

Efficacy and Safety of Gefitinib as Third-line Treatment in NSCLC Patients With Activating EGFR Mutations Treated With First-line Gefitinib Followed by Second-line Chemotherapy: A Single-Arm, Prospective, Multicenter Phase II Study (RE-CHALLENGE, CTONG1304)

American journal of clinical oncology, 2019-05, Vol.42 (5), p.432-439

2019

Volltextzugriff (PDF)

Regulating monocyte infiltration and differentiation: Providing new therapies for colorectal cancer patients with COVID-19

World journal of clinical cases, 2021-12, Vol.9 (34), p.10392-10399

2021

Volltextzugriff (PDF)

Proteomics-based Identification of Human Acute Leukemia Antigens That Induce Humoral Immune Response

Molecular & cellular proteomics, 2005-11, Vol.4 (11), p.1718-1724

2005

Volltextzugriff (PDF)

Cellular immunotherapy combined with platinum-based chemotherapy prolongs survival for non-small cell lung cancer patients

Neoplasma, 2023-04, Vol.70 (2), p.251-259

2023

Volltextzugriff (PDF)

GEMSTONE-301: a phase III clinical trial of CS1001 as consolidation therapy in patients with locally advanced/ unresectable (stage III) non-small cell lung cancer (NSCLC) who did not have disease progression after prior concurrent/sequential chemoradiotherapy

Translational lung cancer research, 2020-10, Vol.9 (5), p.2008-2015

2020

Volltextzugriff (PDF)

Low-dose irradiation inhibits proliferation of the p53null type human prostate cancer cells through the ATM/p21 pathway

International journal of molecular medicine, 2018-01, Vol.41 (1), p.548-554

2018

Volltextzugriff (PDF)

Low-dose irradiation promotes proliferation of the human breast cancer MDA-MB-231 cells through accumulation of mutant P53

International journal of oncology, 2017-01, Vol.50 (1), p.290-296

2017

Volltextzugriff (PDF)

The Potential Clinical Significance of the Serum Iron and Ferritin Status in Lung Cancer Patients

Journal of Nutritional Oncology, 2020-11, Vol.5 (4), p.189-195

2020

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(96)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

First-line atezolizumab plus chemotherapy in treatment of extensive small cell lung cancer: a cost-effectiveness analysis from China

A brand new era of cancer immunotherapy: breakthroughs and challenges

The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively

Cost‐effectiveness analysis of first‐line treatments for advanced epidermal growth factor receptor‐mutant non‐small cell lung cancer patients

Sarcopenia prevalence in patients with cancer and association with adverse prognosis: A nationwide survey on common cancers

Chromosome structural variation in tumorigenesis: mechanisms of formation and carcinogenesis

Association between GLIM-diagnosed malnutrition and quality of life in older patients with cancer

Integrated neutrophil-to-lymphocyte ratio and handgrip strength better predict survival in patients with cancer cachexia

Cost-effectiveness of programmed cell death ligand 1 testing and tumor mutational burden testing of immune checkpoint inhibitors for advanced non-small cell lung cancer

Association of Base Excision Repair Gene Polymorphisms with the Response to Chemotherapy in Advanced Non-Small Cell Lung Cancer

Correlation of circulating tumor DNA EGFR mutation levels with clinical outcomes in patients with advanced lung adenocarcinoma

Diverse and precision therapies open new horizons for patients with advanced pancreatic ductal adenocarcinoma

The Role of Tumor-Infiltrating B Cells in Tumor Immunity

The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis

Lentivirus‑mediated MDA7/IL24 expression inhibits the proliferation of hepatocellular carcinoma cells

Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial

First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial

Efficacy and Safety of Gefitinib as Third-line Treatment in NSCLC Patients With Activating EGFR Mutations Treated With First-line Gefitinib Followed by Second-line Chemotherapy: A Single-Arm, Prospective, Multicenter Phase II Study (RE-CHALLENGE, CTONG1304)

Regulating monocyte infiltration and differentiation: Providing new therapies for colorectal cancer patients with COVID-19

Proteomics-based Identification of Human Acute Leukemia Antigens That Induce Humoral Immune Response

Cellular immunotherapy combined with platinum-based chemotherapy prolongs survival for non-small cell lung cancer patients

GEMSTONE-301: a phase III clinical trial of CS1001 as consolidation therapy in patients with locally advanced/ unresectable (stage III) non-small cell lung cancer (NSCLC) who did not have disease progression after prior concurrent/sequential chemoradiotherapy

Low-dose irradiation inhibits proliferation of the p53null type human prostate cancer cells through the ATM/p21 pathway

Low-dose irradiation promotes proliferation of the human breast cancer MDA-MB-231 cells through accumulation of mutant P53

The Potential Clinical Significance of the Serum Iron and Ferritin Status in Lung Cancer Patients

Suchergebnisse filtern